LCD L39118: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound — Noridian
Orthopedics
Government source· CMS / MACverify ↗HCPCS Level II code
—
No national Medicare fee schedule we hold prices Q4212 — the Physician Fee Schedule lists it with status indicator E (2026 file). CMS fee schedules ↗
Code definition
Code
Q4212
Code system
HCPCS Level II
Full description
Allogen, per cc
CLV Intelligence is tracking 3 policy changes that cite HCPCS Q4212 most recently on 2026-06-05, drawn from 3 LCD/NCD coverage updates. The changes span Orthopedics and Pain Management. 3 are flagged critical or high priority.
Counts reflect the source documents CLV has matched to HCPCS Q4212 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to Q4212
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Orthopedics
Government source· CMS / MACverify ↗+ 1 more alert — subscribe to view
Search Q4212 across all alerts
Full history of CMS and MAC policy changes matched to this code.
Audit documentation
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get alerts when policy changes affect Q4212
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy